TipRanks
Giant Biogene Holding Co. Ltd. (HK:2367)
:2367
Hong Kong Market
2367
Giant Biogene Holding Co. Ltd.
RESEARCH TOOLSreports
Want to see HK:2367 full AI Analyst Report?

Giant Biogene Holding Co. Ltd. (2367) Ratios

11 Followers

Giant Biogene Holding Co. Ltd. Ratios

HK:2367's free cash flow for Q2 2026 was ¥0.79. For the 2026 fiscal year, HK:2367's free cash flow was decreased by ¥ and operating cash flow was ¥0.32. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 10.63 11.27 7.66 7.79 9.03
Quick Ratio
 10.18 10.78 7.29 7.42 8.38
Cash Ratio
 6.21 7.88 4.82 4.72 4.74
Solvency Ratio
 2.01 2.18 2.28 2.47 3.42
Operating Cash Flow Ratio
 2.65 2.37 2.44 3.10 3.32
Short-Term Operating Cash Flow Coverage
 245.59 295.12 0.00 0.00 0.00
Net Current Asset Value
¥ 7.44B¥ 8.11B¥ 5.48B¥ 3.53B¥ 2.24B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.09 1.09 1.13 1.14 1.11
Debt Service Coverage Ratio
 163.75 262.51 8.01K 13.24K 49.01K
Interest Coverage Ratio
 4.82K 7.02K 9.66K 14.86K 53.96K
Debt to Market Cap
 <0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 -2.74 -2.86 -1.74 -1.41 -1.10
Profitability Margins
Gross Profit Margin
79.07%80.34%82.09%83.63%84.39%
EBIT Margin
31.69%38.43%41.13%49.52%49.81%
EBITDA Margin
33.42%39.92%41.70%50.49%50.98%
Operating Profit Margin
31.69%38.43%41.68%47.24%47.92%
Pretax Profit Margin
37.59%42.59%44.37%49.52%49.81%
Net Profit Margin
31.41%34.70%37.23%41.19%42.38%
Continuous Operations Profit Margin
31.40%34.70%37.22%41.09%42.36%
Net Income Per EBT
83.56%81.47%83.91%83.19%85.08%
EBT Per EBIT
118.61%110.82%106.46%104.82%103.94%
Return on Assets (ROA)
16.20%17.65%25.66%29.19%31.93%
Return on Equity (ROE)
17.22%19.31%29.01%33.28%35.36%
Return on Capital Employed (ROCE)
17.70%21.11%32.06%37.48%39.66%
Return on Invested Capital (ROIC)
14.77%17.19%26.87%31.09%33.72%
Return on Tangible Assets
16.21%17.66%25.68%29.24%32.00%
Earnings Yield
7.78%6.06%4.40%4.59%3.46%
Efficiency Ratios
Receivables Turnover
 13.60 27.33 34.48 47.15 34.06
Payables Turnover
 4.45 5.46 3.46 4.33 6.76
Inventory Turnover
 3.13 2.77 3.19 2.88 2.01
Fixed Asset Turnover
 3.96 3.95 4.70 4.95 4.29
Asset Turnover
 0.52 0.51 0.69 0.71 0.75
Working Capital Turnover Ratio
 0.67 0.80 1.21 1.20 1.66
Cash Conversion Cycle
 61.45 78.13 19.46 50.33 138.49
Days of Sales Outstanding
 26.84 13.36 10.59 7.74 10.72
Days of Inventory Outstanding
 116.71 131.59 114.37 126.79 181.80
Days of Payables Outstanding
 82.10 66.82 105.50 84.20 54.03
Operating Cycle
 143.55 144.95 124.96 134.54 192.52
Cash Flow Ratios
Operating Cash Flow Per Share
 1.97 1.79 2.04 1.68 0.95
Free Cash Flow Per Share
 1.74 1.40 1.79 1.45 0.80
CapEx Per Share
 0.23 0.39 0.25 0.23 0.16
Free Cash Flow to Operating Cash Flow
 0.88 0.78 0.88 0.86 0.84
Dividend Paid and CapEx Coverage Ratio
 0.74 1.14 1.77 7.21 1.79
Capital Expenditure Coverage Ratio
 8.42 4.55 8.27 7.21 6.08
Operating Cash Flow Coverage Ratio
 169.05 195.80 304.20 603.68 360.26
Operating Cash Flow to Sales Ratio
 0.39 0.34 0.37 0.47 0.39
Free Cash Flow Yield
8.47%4.68%3.82%4.48%2.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 13.02 16.33 22.75 21.80 28.90
Price-to-Sales (P/S) Ratio
 4.08 5.73 8.47 8.98 12.25
Price-to-Book (P/B) Ratio
 2.28 3.19 6.60 7.25 10.22
Price-to-Free Cash Flow (P/FCF) Ratio
 11.81 21.35 26.15 22.30 37.20
Price-to-Operating Cash Flow Ratio
 10.30 16.66 22.99 19.21 31.08
Price-to-Earnings Growth (PEG) Ratio
 -0.42 -1.27 0.56 0.43 1.62
Enterprise Value Multiple
 9.47 11.50 18.57 16.38 22.92
Enterprise Value
 16.73B 25.32B 42.90B 29.14B 27.63B
EV to EBITDA
 9.47 11.50 18.57 16.38 22.92
EV to Sales
 3.17 4.59 7.74 8.27 11.68
EV to Free Cash Flow
 9.16 17.10 23.91 20.54 35.49
EV to Operating Cash Flow
 8.07 13.34 21.02 17.69 29.66
Tangible Book Value Per Share
 8.92 9.38 7.11 4.45 2.90
Shareholders’ Equity Per Share
 8.91 9.37 7.10 4.45 2.90
Tax and Other Ratios
Effective Tax Rate
 0.16 0.19 0.16 0.17 0.15
Revenue Per Share
 5.03 5.22 5.53 3.59 2.42
Net Income Per Share
 1.58 1.81 2.06 1.48 1.03
Tax Burden
 0.84 0.81 0.84 0.83 0.85
Interest Burden
 1.19 1.11 1.08 1.00 1.00
Research & Development to Revenue
 0.02 0.02 0.02 0.02 0.02
SG&A to Revenue
 0.46 0.40 0.39 0.03 0.05
Stock-Based Compensation to Revenue
 <0.01 <0.01 0.02 <0.01 <0.01
Income Quality
 1.25 1.02 0.83 0.94 0.79
Currency in CNY